
The Impact of COVID-19 on Melanoma Patients
Career Development Award – Rebecca Hartman, MD, MPH
Learn more about our upcoming Galas and Signature Events Learn More
Superyacht Captain, TV Personality, Melanoma Patient and Advocate Poised to Emcee Event Honoring the Melanoma Community New York City, NY (September 11, 2025) – The...
Career Development Award – Rebecca Hartman, MD, MPH
A major obstacle to even the best melanoma therapies is that in the majority of cases, the tumor never completely goes away. Even if a little bit remains, called the minima...
Melanomas arise from pigmented cells called melanocytes, typically in the skin. Melanomas can spread to distal parts of the body, through a process called metastasis. Metas...
Melanoma is the third most common malignancy to metastasize to the brain. It is estimated that at least 50% of patients with stage IV melanoma will develop brain metastases...
Over the past decade, harnessing the power of a patient’s own immune system for the treatment of cancer has been a major medical breakthrough. By using drugs to block inh...
The majority of cancer patients do not yet benefit from immunotherapy, including from immune checkpoint therapies that invigorate the patients’ own immune systems to figh...
Melanoma is one of the fastest growing malignancies and accounts for 5.5% of all new cancer cases in the United States. Treatment options and prognosis of melanoma patients...
Patients with lymph-node positive melanoma have a high risk of recurrence despite curative surgery. While adjuvant therapy given after surgery improves RFS and OS, ~25% of ...
Medical Student Award – Rebecca Chen
Medical Student Award – Michelle Ferreira
Medical Student Award – Hannah Knochelmann
Medical Student Award – Cory Kosche
Oct 16, 2025 ET
Oct 30, 2025 ET